AAAAAA
Results:
1-9
|
Results: 9
Authors:
Monnet, I
Soulie, P
de Cremoux, H
Saltiel-Voisin, S
Bekradda, M
Saltiel, JC
Brain, E
Dupont-Andre, G
Cvitkovic, E
Citation: I. Monnet et al., Phase I/II study of escalating doses of vinorelbine in combination with oxaliplatin in patients with advanced non-small-cell lung cancer, J CL ONCOL, 19(2), 2001, pp. 458-463
Authors:
Fizazi, K
Caliandro, R
Soulie, P
Fandi, A
Daniel, C
Bedin, A
Doubre, H
Viala, J
Rodier, JM
Trandafir, L
Le Chevalier, T
Cvitkovic, E
Armand, JP
Ruffie, P
Citation: K. Fizazi et al., Combination raltitrexed (Tomudex (R))-oxaliplatin: a step forward in the struggle against mesothelioma? The Institut Gustave Roussy experience with chemotherapy and chemo-immunotherapy in mesothelioma, EUR J CANC, 36(12), 2000, pp. 1514-1521
Authors:
Bras-Goncalves, RA
Rosty, C
Laurent-Puig, P
Soulie, P
Dutrillaux, B
Poupon, MF
Citation: Ra. Bras-goncalves et al., Sensitivity to CPT-11 of xenografted human colorectal cancers as a function of microsatellite instability and p53 status, BR J CANC, 82(4), 2000, pp. 913-923
Authors:
Bernard, MH
Massart, C
Werneau, JL
Schlienger, JL
Mlika-Cabanne, N
Blouin, P
Bukowski, JV
Chupin, M
Collignon, I
De Boysson, M
Isnard, R
Jamet, JL
Kaloustian, E
Mas, JL
Massart, C
Mira, R
Rohmer, V
Rousset, H
Soulie, P
Teslar, E
Mlika-Cabanne, N
Alix, M
Archambeaud, F
Aubert, L
Baldet, L
Beutter, D
Caron, P
Chabrier, G
Chantegreil, F
Chapuis, J
Cohen-Solal, A
Conte-Devoix, B
Couplet, G
Dany, F
Daver, A
Doucet, J
Dreyfus, M
Du Rostu, H
Gay, B
Giraud, P
Gruson, A
Gerber, F
Guillausseau, C
Houlbert, C
Kahn, R
Lagarde, J
Laisne, C
Legrand, JL
Leveque, M
Martinet, C
Millet, A
Nambotin, P
Orgiazzi, J
Pochet, P
Potier, A
Pouget-Abadie, JF
Rouanet, G
Rymer, JC
Sadoul, JL
Sapin, R
Tardieu, J
Thibon, R
Vetel, JM
Wemeau, JL
Winiszewski, P
Citation: Mh. Bernard et al., Laboratory diagnosis and follow-up of adults with hyperthyroidism, ANN ENDOCR, 61(3), 2000, pp. 284-287
Authors:
Soulie, P
Poupon, MF
Remvikos, Y
Dutrillaux, B
Muleris, M
Citation: P. Soulie et al., Distinct chromosomal alterations associated with TP53 status of LoVo cellsunder PALA selective pressure: a parallel with cytogenetic pathways of colorectal cancers, ONCOGENE, 18(3), 1999, pp. 775-781
Authors:
Germann, N
Brienza, S
Rotarski, M
Emile, JF
Di Palma, M
Musset, M
Reynes, M
Soulie, P
Cvitkovic, E
Misset, JL
Citation: N. Germann et al., Preliminary results on the activity of oxaliplatin (L-OHP) in refractory recurrent non-Hodgkin's lymphoma patients, ANN ONCOL, 10(3), 1999, pp. 351-354
Authors:
Brienza, S
Bensmaine, MA
Soulie, P
Louvet, C
Gamelin, E
Francois, E
Ducreux, M
Marty, M
Andre, T
de Braud, F
Bleiberg, H
Segal, V
Itzhaki, M
Cvitkovic, E
Citation: S. Brienza et al., Oxaliplatin added to 5-fluorouracil-based therapy (5-FU +/- FA) in the treatment of 5-FU-pretreated patients with advanced colorectal carcinoma (ACRC): Results from the European compassionate-use program, ANN ONCOL, 10(11), 1999, pp. 1311-1316
Authors:
Soulie, P
Garrino, C
Bensamaine, MA
Bekradda, M
Brain, E
Di Palma, M
Goupil, A
Misset, JL
Cvitkovic, E
Citation: P. Soulie et al., Antitumoral activity of oxaliplatin/cisplatin-based combination therapy incisplatin-refractory germ cell cancer patients, J CANC RES, 125(12), 1999, pp. 707-711
Authors:
Soulie, P
Fourme, E
Hamelin, R
Asselain, B
Salmon, RJ
Dutrillaux, B
Muleris, M
Citation: P. Soulie et al., TP53 status and gene amplification in human colorectal carcinomas, CANC GENET, 115(2), 1999, pp. 118-122
Risultati:
1-9
|